Author: Dale HewettImportant: This article is for educational purposes and is not medical advice. CBD is not approved by the FDA to treat, cure, or prevent cancer. If you have been diagnosed with cancer, please follow the treatment plan your oncologist recommends and discuss any supplement before adding it to your routine.
Cannabidiol (CBD) has become one of the most-discussed plant compounds in wellness conversations, and that interest naturally extends to people navigating a cancer diagnosis or supporting a loved one through cancer care. This page summarizes what published research has actually examined, what it has not, and why the FDA distinguishes consumer CBD products from approved cancer medications.
Quick Summary:
- CBD is not a treatment for cancer. No CBD product on the consumer market has been approved by the FDA for any cancer indication.
- A small number of cannabinoid-based prescription medications — for example, Marinol (dronabinol) and Cesamet (nabilone) — are FDA-approved for chemotherapy-induced nausea and vomiting in specific clinical situations. These are pharmaceutical-grade, prescribed medications, not over-the-counter CBD.
- Some patients in cancer care report using CBD products to support sleep, general comfort, and stress, and a number of preliminary studies have looked at cannabinoids in this supportive-care context. Findings remain early and any decision to use CBD belongs in a conversation with the oncology team.
What “FDA-approved” actually means in this conversation
The FDA has approved a handful of cannabinoid-based medications, all of which are prescription drugs reviewed through formal clinical trials:
- Epidiolex (cannabidiol) — approved for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex
- Marinol / Syndros (dronabinol, a synthetic THC) — approved for AIDS-related anorexia and chemotherapy-induced nausea and vomiting that has not responded to standard antiemetics
- Cesamet (nabilone, a synthetic cannabinoid) — approved for chemotherapy-induced nausea and vomiting
Consumer CBD oils, gummies, and tinctures are dietary supplements, not drugs. They are not interchangeable with these prescription medications, and brands legally cannot claim they treat cancer or any other disease.
What researchers have actually studied
Most CBD-and-cancer research falls into three buckets, and it’s worth being honest about the limitations of each.
Preclinical (cell and animal) studies
A meaningful body of laboratory research has examined how cannabinoids interact with cancer cells in petri dishes and in animal models. Some of these studies have observed effects on cell signaling pathways relevant to tumor biology. Preclinical results are interesting hypothesis-generators, but they routinely fail to translate into human benefit, which is why the FDA requires controlled clinical trials before any treatment claim can be made.
Supportive-care studies in patients
A separate research strand looks at whether cannabinoids may help with symptoms that often accompany cancer or its treatments — for example, chemotherapy-induced nausea, appetite changes, sleep disruption, and pain. The strongest evidence here is for the prescription cannabinoid medications listed above, not for consumer CBD. Individual studies of CBD specifically for cancer-related symptoms are limited in size and quality.
Quality-of-life and patient-reported outcome studies
Some surveys and observational studies report that patients in cancer care who use CBD describe improvements in sleep or general comfort. Self-report studies cannot establish that CBD caused those improvements — placebo effects, expectation effects, and concurrent medications all influence what people report.
Why the FDA has sent warning letters about cancer claims
The FDA has repeatedly warned and fined companies that market CBD products with cancer-related claims. In its public guidance the agency makes the position plain: marketing a product as able to treat, cure, or prevent cancer makes that product an unapproved new drug under federal law. This is true even when the company adds disclaimers elsewhere on the page.
That is why authoritative health publications, hospital systems, and reputable CBD brands describe research findings carefully and never say a product “fights cancer,” “shrinks tumors,” or “is a cancer treatment.”
Drug-interaction considerations
This part matters in a cancer-care context. CBD is metabolized by the same liver enzymes (CYP3A4, CYP2C19) that process many oncology medications, which means CBD can change the blood levels of those drugs and either reduce their effectiveness or increase side-effect risk. Examples your oncologist or pharmacist can speak to specifically:
- Some chemotherapy agents
- Certain immunotherapy regimens
- Anticoagulants such as warfarin
- Tamoxifen and other endocrine therapies
Anyone undergoing cancer treatment should disclose CBD use to their oncologist and pharmacist before starting it.
What to ask your oncology team
If you are curious about CBD as part of your supportive-care plan, an honest conversation with your medical team is the right next step. Useful questions include:
- Are any of my prescribed medications metabolized through CYP3A4 or CYP2C19?
- Is there any reason I should not use a CBD product alongside my current treatment?
- If I were to try a CBD product, what type, what dose, and on what timing would you suggest I report back about?
- Are there any clinical trials I should know about?
What we offer at New Phase Blends
We make third-party-tested CBD products designed for general wellness use. Our products are not formulated, tested, or marketed as treatments for cancer or any other disease. If you choose to use them, please do so as part of a routine your medical team is aware of.
Frequently asked questions
Does CBD oil cure cancer? No. There is no scientific evidence that any consumer CBD product cures cancer.
Has any CBD product been FDA-approved for cancer? No consumer CBD product has been FDA-approved for cancer. A small number of prescription cannabinoid medications are approved for chemotherapy-induced nausea or AIDS-related anorexia.
Can CBD interfere with chemotherapy? It can. CBD shares liver-enzyme pathways with many chemotherapy and supportive-care drugs and may alter their blood levels. Discuss CBD with your oncologist and pharmacist before using it during treatment.
Where can I learn more about how CBD interacts with the body? Our endocannabinoid system overview explains the underlying biology in plain language.
